Phase I Trial of the Antivascular Agent Combretastatin A4 Phosphate on a 5-Day Schedule to Patients With Cancer: Magnetic Resonance Imaging Evidence for Altered Tumor Blood FlowJames Stevenson, Peter J. O’Dwyer, David J. Chaplin et al.|Journal of Clinical Oncology|2003Cited by 293
Phase I Trial of Combretastatin A-4 Phosphate with CarboplatinJoshua H. Bilenker, Peter J. O’Dwyer, Keith T. Flaherty et al.|Clinical Cancer Research|2005Cited by 99
Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinomaWeijing Sun, Kim M. Olthoff, Davendra Sohal et al.|Cancer|2011Cited by 97
A phase II trial of gemcitabine, irinotecan and panitumumab in advanced cholangiocarcinomaDavendra Sohal, Weijing Sun, Kristine Mykulowycz et al.|Annals of Oncology|2013Cited by 89
Selenium suppresses inflammation by inducing microRNA-146a in <i>Staphylococcus aureus</i>-infected mouse mastitis modelWeijing Sun, Mengyao Guo|Oncotarget|2017Cited by 22